Clinical studies recruiting near Bellinzona

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Ospedale Regionale Bellinzona e Valli · Bristol-Myers Squibb · NCT07106762 Swiss Registry for Neuromuscular Disorders
Phase N/A · Pediatric Institute of Southern Switzerland, Ospedale San Gi · University of Bern · NCT05102916 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Istituto Oncologico della Svizzera Italiana · Amgen · NCT04221542 A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Phase 1/Phase 2 · Istituto Oncologico, Ospedale Bellinzona e Valli · Orion Corporation, Orion Pharma · NCT06725758 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Oncology Institute of Southern Switzerland and Institute of · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Diagnosis of Tuberculosis in Swiss Children
Phase N/A · Ospedale Regionale di Bellinzona · University Children's Hospital Basel · NCT03044509 Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Phase 1/Phase 2 · Oncolgy Institute of Southern Switzerland (IOSI) · Institute of Cancer Research, United Kingdom · NCT06126731 Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · Pediatric Institute of Southern Switzerland, Ospedale San Gi · University of Bern · NCT05017142 SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumour
NA · Ospedale San Giovanni · Institut Curie · NCT05192980 Evaluation and Comparison Between General Anesthesia VS Two Types of Combined Anesthesia for Opioid Consumption in Lapar
NA · Ente Ospedaliero Cantonale ORBV · Andrea Saporito · NCT06642649 Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surge
NA · Oncology Institute of Southern Switzerland (IOSI) · Oncology Institute of Southern Switzerland · NCT07235098 Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Phase 1 · Ospedale Regionale Bellinzona e Valli ( Site 0104) · Merck Sharp & Dohme LLC · NCT07600749 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Ospedale San Giovanni Pediatria, Emato-oncologia pediatrica · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0341 · Bristol-Myers Squibb · NCT06561386 Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Phase 2 · Oncology Institute of Southern Switzerland · Oncology Institute of Southern Switzerland · NCT05748145 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 PUSHES (Pudendal Block Versus Sacral ESP Hemorrhoidectomy Study)
NA · Ospedale Regionale Bellinzona e Valli (ORBV) CH-6500 Bellinz · Andrea Saporito · NCT07350460 MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Phase 3 · Oncology Institute of Southern Switzerland (IOSI)-Ente Osped · Swiss GO Trial Group · NCT04111978 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Ospedale San Giovanni · University Hospital Muenster · NCT04043494 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Ospedale San Giovanni Bellinzona · Martin Schrappe · NCT03643276 Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2 · Istituto Oncologico della Svizzera Italiana (IOSI) · Swiss Cancer Institute · NCT06401980 A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymph
Phase 1/Phase 2 · Ospedale Regionale Bellinzona e Valli · Bristol-Myers Squibb · NCT06090539 Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery
NA · Ospedale Regionale di Bellinzona, San Giovanni · Ente Ospedaliero Cantonale, Bellinzona · NCT06355271 Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
Phase 2 · Ospedale Regionale di Bellinzona · University of Zurich · NCT06563362 High Dose Steroids in Children With Stroke
Phase 3 · Ospedale Regionale di Bellinzona e Valli · Insel Gruppe AG, University Hospital Bern · NCT04873583 A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-s
Phase 3 · Eoc - Iosi · ETOP IBCSG Partners Foundation · NCT06284317 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Phase 3 · Istituto Oncologico della Svizzera Italiana · Philogen S.p.A. · NCT03567889 Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Phase 3 · Oncology Institute of Southern Switzerland (IOSI) - Oncology · European Organisation for Research and Treatment of Cancer - · NCT05815927 Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NA · IOSI Ospedale Regionale di Bellinzona e Valli · Swiss Cancer Institute · NCT06114108 International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Phase N/A · Ente Ospedaliero Cantonale · Prostate Cancer Clinical Trials Consortium · NCT03151629

Look up another city

Look up another condition